Researchers aim to use AI for early screening and prognosis of Dry Eye Disease

Dry Eye Disease (DED) is one of the more common eye diseases, affecting up to 30% of the world’s population.

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.

January 9, 2024

Uni-Bio Science Group Limited Announces 2024 Interim Results – Biotech Investments

EQS Newswire / 28/08/2024 / 19:52 UTC+8 Achieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4M Further Penetration to Osteoporosis, Ophthalmology, and Medical

August 29, 2024

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

In this interview conducted at Pittcon 2024 in San Diego, we spoke to Richard Crocombe about his journey in the field of spectroscopy, focusing on

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.